Deep Tech Startups

Parallel Venture Capital is an early-stage investment firm that backs U.S. and allied-founded startups developing dual-use technologies serving both government and commercial customers. It focuses on defense and national security applications, connecting portfolio companies to the Department of Defense, Intelligence Community, and allied partners.

1 investor

Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets. The platform pairs programmable target binding with payload presentation to localize drug exposure and engineer delivery around the therapeutic window.

1 investor

Paras Aqua develops land-based aquaculture systems focused on fish welfare and sustainable production. The company offers the Paras Precision Hybrid Flow-through System, a patented technology that improves water reuse, operational efficiency, and profitability for fish farming facilities.

1 investor

Parasma develops algorithms and infrastructure to train living neural systems for computation, aiming to make advanced AI far more energy-efficient and accessible by leveraging biological neurons as programmable compute. The company serves organizations seeking to reduce the energy footprint and hardware costs of AI systems.

1 investor

Parkway VC is a venture capital firm that invests in early and mid-stage companies across technology, sustainable energy, and disruptive innovations, with a focus on scaling high-growth ventures. The firm's team brings deep entrepreneurial and operational expertise, with partners holding experience from major financial institutions and successful exits across multiple sectors.

1 investor

Parry builds integrated mission systems combining software, hardware, and AI-enabled autonomy that operate across platforms and environments without requiring custom integration. The company serves warfighters and defense organizations by delivering reliable, coordinated systems for tactical edge operations.

1 investor

Parsed trains and deploys specialized large language models tailored to a customer's domain and workflow, using an evaluation-first, continual-learning approach aimed at outperforming general-purpose models while being cheaper and faster. It targets enterprises in regulated and mission-critical sectors such as healthcare and insurance, offering multicloud inference, interpretability, and reinforcement learning for ongoing model improvement.

1 investor

Runway is an AI company building multimodal simulators to model the world through the integration of art and science, with a global team of researchers, engineers, artists, and designers.

1 investor

Pasithea is a biotechnology company focused on the discovery and development of therapeutics for central nervous system disorders and RASopathies. Its research targets conditions including Neurofibromatosis type 1 (NF1), ALS, multiple sclerosis, and schizophrenia.

1 investor

Patentix is a Ritsumeikan University spin-off that develops and manufactures new functional materials, with a focus on ultra-wide-bandgap rutile germanium dioxide (r-GeO₂) for next-generation power semiconductors. The company works on crystal growth, thin-film fabrication, and device development, and sells research samples and materials to industry.

1 investor

Patina develops technology to analyze and reproduce scent, working with perfumers and creative partners to create novel fragrances. Its work ranges from high-fidelity replication of natural materials like Bulgarian Rose Otto to unconventional scent profiles.

1 investor

Patina develops technology to understand and create novel scents, working with perfumers and creative partners to produce fragrances ranging from high-fidelity replication of natural materials to entirely new aromas. It operates in the fragrance and scent technology space.

1 investor

Pax VC is a venture capital firm that invests in founders building technologies in foundational and physical-world industries such as defense, aerospace, energy, and industrial supply chains. It focuses on early-stage ("zero to one") companies working on hardware, deeptech, and dual-use technologies.

1 investor

Paxray is a task mining tool that automatically captures anonymised employee interactions across systems (ERP, CRM, email, browser, Office) over time to generate objective process documentation and BPMN diagrams for tools like Signavio, Camunda or Visio. It serves organisations preparing for compliance, ISO certifications, RPA/AI automation, IT modernisation, ERP/CRM migrations and post-merger integration.

1 investor

PCN Materials produces a patented photocatalytic material based on modified titanium oxide for air and water purification, disinfection, and bacterial control in indoor spaces and health-sensitive facilities. The company applies its technology in large-scale infrastructure projects including road tunnels and medical facilities.

1 investor

Precision Cardiovascular develops implantable cardiac monitoring devices for heart failure patients, focusing on exercise and stress monitoring gaps in current clinical systems. The company is advancing next-generation sensor technology through regulatory review and clinical evaluation processes.

1 investor

Peak Nano develops nanolayered metamaterial films and capacitor products for energy storage, defense, aerospace, and infrastructure applications. The company manufactures advanced materials in the United States, serving customers in power grids, fusion energy, electric vehicles, and heavy equipment industries.

1 investor

Peak Quantum develops error-protected superconducting quantum processing units (QPUs) designed for fault tolerance at the hardware level, reducing the need for active quantum error correction and the number of physical qubits required. The company targets scalable, industrial-grade quantum computing and works with investors, integrators, and researchers.

1 investor

Pearl Bio develops technologies for genome engineering, ribosome engineering, and biomanufacturing to enable production of novel proteins, chemicals, and materials for biotechnology and medicine.

1 investor

Pelagos Pharma develops drugs targeting hard-to-treat receptors for age-related diseases, with a focus on extending healthspan and longevity.

1 investor

Pending AI develops a drug discovery and development platform using quantum mechanics and artificial intelligence to enable pharmaceutical companies to develop medicines for any disease. The company serves pharmaceutical partners in asset co-development.

1 investor

Per Aspera is a media platform covering America's technological, industrial, and cultural infrastructure across defense, space, energy, computing, and manufacturing sectors. The platform publishes analysis, teardowns, and commentary for practitioners building critical American capabilities, with content reaching audiences at NASA, SpaceX, the Pentagon, and leading defense contractors.

1 investor

Per Vices designs and manufactures software-defined radios (SDRs) for mission-critical applications, offering both commercial off-the-shelf solutions and custom designs. The company serves defense, communications, and other industries requiring high-performance radio systems.

1 investor

PERA Global is a Chinese CAE (Computer-Aided Engineering) simulation software company that develops autonomous engineering simulation tools and AI-powered digital twin technologies for high-end manufacturing across aerospace, defense, automotive, and other industrial sectors. The company serves over 5,000 customers, including 70% state-owned and military enterprises, and provides simulation software and consulting services to support China's advanced manufacturing and digital transformation.

1 investor